SCHEMBL930874

SCHEMBL930874

CCC(CC)Oc1cccc(C(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.61
FOLH1 Q04609 1/20 0.56
AKR1C3 P42330 1/20 0.56
NR4A2 P43354 4/20 0.53
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
POLB P06746 1/20 0.51
CYP2C9 P11712 1/20 0.51
NR1H4 Q96RI1 3/20 0.50
PLA2G4B P0C869 1/20 0.49
NR4A1 P22736 1/20 0.48
NR4A3 Q92570 1/20 0.48
MITF O75030 1/20 0.48
TP53 P04637 1/20 0.48
PKM P14618 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9005653 0.87 KMT2A (0.62) KMT2AFOLH1AKR1C3NR4A2NPC1
SCHEMBL17309757 0.86 KMT2A (0.61) KMT2AFOLH1AKR1C3NR4A2NPC1
SCHEMBL931250 0.85 KMT2A (0.59) KMT2AFOLH1AKR1C3NR4A2NPC1
SCHEMBL27443684 0.85 PARP1 (0.62) KMT2APLAU
SCHEMBL17060024 0.84 PLA2G2A (0.46) KMT2AFOLH1CYP2C9TP53SMN1; SMN2
Hydrochloric Acid SCHEMBL28244745 0.83 PARP1 (0.60) KMT2APLAU
SCHEMBL9337588 0.83 KMT2A (0.58) KMT2AFOLH1AKR1C3NR4A2NPC1
SCHEMBL931301 0.82 CA12 (0.53) KMT2ANPC1RAB9APOLBPKM
SCHEMBL28885870 0.82 KMT2A (0.56) KMT2AFOLH1AKR1C3NPC1RAB9A
SCHEMBL9440013 0.82 KMT2A (0.56) KMT2AFOLH1AKR1C3NR4A2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120183660-A1 ISOMANNIDE DERIVATIVES AND THEIR USE AS TASTANTS SENOMYX, INC. (US) 2012-07-19 US disclosed
EP-2448944-A2 ISOMANNIDE DERIVATIVES AND THEIR USE AS TASTANTS Senomyx, Inc. (US) 2012-05-09 EP disclosed
WO-2011002871-A2 ISOMANNIDE DERIVATIVES AND THEIR USE AS TASTANTS SENOMYX, INC (US) 2011-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120183660-A1 ISOMANNIDE DERIVATIVES AND THEIR USE AS TASTANTS TAS2R41, TAS2R42, TAS2R40 KMT2A 3094/4885FOLH1 3607/4885AKR1C3 2334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.